Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis

Affiliations

• ¹ Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
• ² Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.
• ³ Department of Biomedicine, Translational Research and Personalised Medicine, University of Granada, Granada, Spain.
• ⁴ Department of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain.
• ⁵ Department of Medicine, Faculty of Health Sciences, University of Jaén, Jaén, Spain.
• ⁶ Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
• ⁷ Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS, Granada, Spain.
• ⁸ Instituto de Investigación Biosanataria IBs.Granada, Granada, Spain.
• ⁹ Consortium for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain.
• ¹⁰ Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
• ¹¹ Biopathology and Regenerative Medicine Institute, Centre for Biomedical Research, University of Granada, Granada, Spain.
• ¹² Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.
• ¹³ Excellence Research Unit "Modeling Nature" (MNat), University of Granada, Granada, Spain.
• ¹⁴ Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain.